CD8A and non-small cell lung carcinoma: Recently, preclinical mouse models discovered that liver metastasis drained activated CD8+ T cells from the systemic circulation and triggered CD8+ T cell death, resulting in a systemic immunological desert, implying that immunotherapy effectiveness for NSCLC patients with liver metastasis is diminished [10].